# Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers

> **NCT01535859** · PHASE3 · COMPLETED · sponsor: **KK Women's and Children's Hospital** · enrollment: 46 (actual)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** Cabergoline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01535859
- **Lead sponsor:** KK Women's and Children's Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2015-06
- **Final completion:** 2016-06
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535859, "Study of Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in In Vito Fertilization Cycles and Derivation of OHSS Biomarkers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01535859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*